BridgeBio Oncology Therapeutics, Inc. (BBOT) Deferred Tax Assets, Operating Loss Carryforwards, State and Local

BridgeBio Oncology Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards, State and Local

BridgeBio Oncology Therapeutics, Inc. (BBOT) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $129.80 million as of 2025-12-31, per its POS AM filed 2026-04-30.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2026-04-30

• 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $129.80M.